- Home
- INM
INM
InMed Pharmaceuticals Inc.
as 12-18-2024 4:00pm EST
| Founded: | 1981 | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 30.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -13.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.42 - $15.70 | Next Earning Date: | 02-11-2025 |
| Revenue: | $4,960,506 | Revenue Growth: | 5.17% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest InMed Pharmaceuticals Inc. News
INM Breaking Stock News: Dive into INM Ticker-Specific Updates for Smart Investing
Newsfile
a day ago
InMed Enters Into Standby Equity Purchase Agreement
Newsfile
a month ago
InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
Newsfile
a month ago
InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
Newsfile
a month ago
InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules
Newsfile
a month ago
InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules
Newsfile
2 months ago
InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease
Newsfile
2 months ago
InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease
Newsfile
2 months ago
InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board
Compare INM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INM InMed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.